NL7610300A - Werkwijze voor het bereiden van 4-(polyalkyl-fe- nyl)-2-pyrrolidonen en werkwijze voor de berei- ding van een geneesmiddel met neuro-psychotrope werking. - Google Patents
Werkwijze voor het bereiden van 4-(polyalkyl-fe- nyl)-2-pyrrolidonen en werkwijze voor de berei- ding van een geneesmiddel met neuro-psychotrope werking.Info
- Publication number
- NL7610300A NL7610300A NL7610300A NL7610300A NL7610300A NL 7610300 A NL7610300 A NL 7610300A NL 7610300 A NL7610300 A NL 7610300A NL 7610300 A NL7610300 A NL 7610300A NL 7610300 A NL7610300 A NL 7610300A
- Authority
- NL
- Netherlands
- Prior art keywords
- preparing
- procedure
- pyrrolidones
- polyalkyl
- nyl
- Prior art date
Links
- 229940126601 medicinal product Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
- C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19752541855 DE2541855A1 (de) | 1975-09-18 | 1975-09-18 | 4-(polyalkoxy-phenyl)-2-pyrrolidone ii |
Publications (1)
Publication Number | Publication Date |
---|---|
NL7610300A true NL7610300A (nl) | 1977-03-22 |
Family
ID=5956927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL7610300A NL7610300A (nl) | 1975-09-18 | 1976-09-16 | Werkwijze voor het bereiden van 4-(polyalkyl-fe- nyl)-2-pyrrolidonen en werkwijze voor de berei- ding van een geneesmiddel met neuro-psychotrope werking. |
Country Status (18)
Country | Link |
---|---|
US (1) | US4153713A (xx) |
JP (1) | JPS5236659A (xx) |
AT (1) | AT349459B (xx) |
BE (1) | BE846335R (xx) |
CA (1) | CA1077496A (xx) |
CH (1) | CH623571A5 (xx) |
CS (1) | CS225802B2 (xx) |
DD (1) | DD126894A6 (xx) |
DE (1) | DE2541855A1 (xx) |
DK (1) | DK157919C (xx) |
ES (1) | ES451518A2 (xx) |
FR (1) | FR2324299A2 (xx) |
GB (1) | GB1563398A (xx) |
HU (1) | HU173117B (xx) |
IE (1) | IE43723B1 (xx) |
NL (1) | NL7610300A (xx) |
SE (1) | SE407799B (xx) |
SU (1) | SU795465A3 (xx) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1124247A (en) * | 1979-08-09 | 1982-05-25 | Hoffmann-La Roche Limited | Pyrrolidine derivatives |
WO1987006576A1 (en) * | 1986-04-29 | 1987-11-05 | Pfizer Inc. | Calcium independent camp phosphodiesterase inhibitor antidepressant |
US5459145A (en) * | 1988-01-19 | 1995-10-17 | Pfizer Inc. | Calcium independent camp phosphodiesterase inhibitor antidepressant |
YU162789A (en) * | 1988-09-01 | 1990-12-31 | Lonza Ag | 2-aza-4-(alcoxycarbonyl) spiro/4,5/decan-3-ones |
JP2578001B2 (ja) * | 1989-12-11 | 1997-02-05 | 明治製菓株式会社 | 抗痴呆薬 |
AU8292091A (en) * | 1990-08-03 | 1992-03-02 | Smithkline Beecham Corporation | Tnf inhibitors |
DE4032055A1 (de) * | 1990-10-05 | 1992-04-09 | Schering Ag | Verfahren zur herstellung von optisch aktiven 4-aryl-2-pyrrolidinonen |
KR0133550B1 (ko) * | 1991-01-21 | 1998-04-23 | 요시또시 가즈오 | 3-벤질리덴-1-카르바모일-2-피롤리돈 유사체 |
US5514678A (en) * | 1992-03-26 | 1996-05-07 | E. I. Du Pont De Nemours And Company | Arthropodicidal 1,2,4-triazinyl amides |
US5547979A (en) * | 1992-03-30 | 1996-08-20 | Smithkline Beecham | TNF inhibition |
US5395935A (en) * | 1992-05-08 | 1995-03-07 | Pfizer Inc. | Endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents |
GB9212673D0 (en) * | 1992-06-15 | 1992-07-29 | Celltech Ltd | Chemical compounds |
GB9222253D0 (en) * | 1992-10-23 | 1992-12-09 | Celltech Ltd | Chemical compounds |
US5622977A (en) * | 1992-12-23 | 1997-04-22 | Celltech Therapeutics Limited | Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same |
GB9226830D0 (en) * | 1992-12-23 | 1993-02-17 | Celltech Ltd | Chemical compounds |
GB9304920D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
GB9304919D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
US5665754A (en) * | 1993-09-20 | 1997-09-09 | Glaxo Wellcome Inc. | Substituted pyrrolidines |
GB9326173D0 (en) * | 1993-12-22 | 1994-02-23 | Celltech Ltd | Chemical compounds and process |
ATE260911T1 (de) * | 1993-12-22 | 2004-03-15 | Celltech R&D Ltd | Trisubstituierte phenyl-derivate, verfahren zu deren herstellung und deren verwendung als phosphodiesterase (typ iv) hemmstoffe |
US5672622A (en) * | 1994-04-21 | 1997-09-30 | Berlex Laboratories, Inc. | Treatment of multiple sclerosis |
US6060501A (en) * | 1994-06-02 | 2000-05-09 | Schering Aktiengesellschaft | Combined treatment of multiple sclerosis |
US6245774B1 (en) | 1994-06-21 | 2001-06-12 | Celltech Therapeutics Limited | Tri-substituted phenyl or pyridine derivatives |
US5786354A (en) * | 1994-06-21 | 1998-07-28 | Celltech Therapeutics, Limited | Tri-substituted phenyl derivatives and processes for their preparation |
GB9412571D0 (en) * | 1994-06-22 | 1994-08-10 | Celltech Ltd | Chemical compounds |
GB9412573D0 (en) * | 1994-06-22 | 1994-08-10 | Celltech Ltd | Chemical compounds |
GB9412672D0 (en) * | 1994-06-23 | 1994-08-10 | Celltech Ltd | Chemical compounds |
IL117090A (en) * | 1995-02-10 | 2000-07-26 | Schering Ag | Pharmaceutical compositions containing oxazolidinone derivatives |
DE19540475A1 (de) * | 1995-10-20 | 1997-04-24 | Schering Ag | Chirale Methylphenyloxazolidinone |
GB9523675D0 (en) | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
GB9526246D0 (en) * | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
GB9526243D0 (en) * | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
GB9526245D0 (en) * | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
GB9608435D0 (en) * | 1996-04-24 | 1996-06-26 | Celltech Therapeutics Ltd | Chemical compounds |
GB9619284D0 (en) * | 1996-09-16 | 1996-10-30 | Celltech Therapeutics Ltd | Chemical compounds |
GB9622363D0 (en) * | 1996-10-28 | 1997-01-08 | Celltech Therapeutics Ltd | Chemical compounds |
GB9625184D0 (en) * | 1996-12-04 | 1997-01-22 | Celltech Therapeutics Ltd | Chemical compounds |
EP0946523A1 (en) | 1996-12-23 | 1999-10-06 | Celltech Therapeutics Limited | Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors |
GB9705361D0 (en) * | 1997-03-14 | 1997-04-30 | Celltech Therapeutics Ltd | Chemical compounds |
GB9713087D0 (en) * | 1997-06-20 | 1997-08-27 | Celltech Therapeutics Ltd | Chemical compounds |
GB9914258D0 (en) * | 1999-06-18 | 1999-08-18 | Celltech Therapeutics Ltd | Chemical compounds |
GB9924862D0 (en) * | 1999-10-20 | 1999-12-22 | Celltech Therapeutics Ltd | Chemical compounds |
RU2330024C2 (ru) * | 2001-05-29 | 2008-07-27 | Шеринг Акциенгезельшафт | Ингибирующие cdk-киназы пиримидины, способ их получения и их применение в качестве лекарственных средств |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA709405A (en) * | 1965-05-11 | Parke, Davis And Company | Methods for producing pyrrolidine compounds | |
US2975193A (en) * | 1959-06-18 | 1961-03-14 | Parke Davis & Co | Organic amine compounds and method of obtaining the same |
FR1516776A (fr) * | 1966-07-21 | 1968-03-15 | Rhone Poulenc Sa | Nouveaux dérivés du pyrrole et leur préparation |
US3647790A (en) * | 1969-04-08 | 1972-03-07 | American Home Prod | Ouinoxalinyl-oxazolidines and -oxazines |
US3644398A (en) * | 1969-04-11 | 1972-02-22 | Robins Co Inc A H | 1-carbamoyl-3-phenylpyrrolidines |
GB1350582A (en) * | 1970-07-24 | 1974-04-18 | Ucb Sa | Cerivatives of 2-pyrrolidinone |
US3956314A (en) * | 1970-07-24 | 1976-05-11 | U.C.B., Societe Anonyme | Derivatives of 2-pyrrolidinone |
JPS5232064B2 (xx) * | 1972-06-14 | 1977-08-19 | ||
DE2413935A1 (de) * | 1974-03-20 | 1975-10-16 | Schering Ag | 4-(polyalkoxy-phenyl)-2-pyrrolidone |
-
1975
- 1975-09-18 DE DE19752541855 patent/DE2541855A1/de not_active Withdrawn
-
1976
- 1976-07-05 CH CH857676A patent/CH623571A5/de not_active IP Right Cessation
- 1976-07-28 SU SU762385904A patent/SU795465A3/ru active
- 1976-09-10 DK DK408676A patent/DK157919C/da not_active IP Right Cessation
- 1976-09-14 ES ES451518A patent/ES451518A2/es not_active Expired
- 1976-09-15 IE IE2052/76A patent/IE43723B1/en unknown
- 1976-09-16 NL NL7610300A patent/NL7610300A/xx not_active Application Discontinuation
- 1976-09-16 DD DD194827A patent/DD126894A6/xx not_active IP Right Cessation
- 1976-09-16 SE SE7610275A patent/SE407799B/xx not_active IP Right Cessation
- 1976-09-17 JP JP51111693A patent/JPS5236659A/ja active Granted
- 1976-09-17 CS CS766054A patent/CS225802B2/cs unknown
- 1976-09-17 FR FR7627961A patent/FR2324299A2/fr active Granted
- 1976-09-17 BE BE170731A patent/BE846335R/xx not_active IP Right Cessation
- 1976-09-17 AT AT690776A patent/AT349459B/de not_active IP Right Cessation
- 1976-09-17 HU HU76SC578A patent/HU173117B/hu unknown
- 1976-09-17 CA CA261,454A patent/CA1077496A/en not_active Expired
- 1976-09-17 US US05/724,213 patent/US4153713A/en not_active Expired - Lifetime
- 1976-09-20 GB GB38887/76A patent/GB1563398A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
HU173117B (hu) | 1979-02-28 |
JPS5236659A (en) | 1977-03-22 |
IE43723L (en) | 1977-03-18 |
CS225802B2 (en) | 1984-02-13 |
SU795465A3 (ru) | 1981-01-07 |
SE7610275L (sv) | 1977-03-19 |
DK157919B (da) | 1990-03-05 |
DK157919C (da) | 1990-08-06 |
DE2541855A1 (de) | 1977-03-31 |
FR2324299B2 (xx) | 1980-02-01 |
DK408676A (da) | 1977-03-19 |
IE43723B1 (en) | 1981-05-06 |
SE407799B (sv) | 1979-04-23 |
JPS612660B2 (xx) | 1986-01-27 |
DD126894A6 (xx) | 1977-08-17 |
ATA690776A (de) | 1978-09-15 |
US4153713A (en) | 1979-05-08 |
ES451518A2 (es) | 1977-10-01 |
AT349459B (de) | 1979-04-10 |
FR2324299A2 (fr) | 1977-04-15 |
GB1563398A (en) | 1980-03-26 |
CA1077496A (en) | 1980-05-13 |
BE846335R (fr) | 1977-03-17 |
CH623571A5 (xx) | 1981-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL7610300A (nl) | Werkwijze voor het bereiden van 4-(polyalkyl-fe- nyl)-2-pyrrolidonen en werkwijze voor de berei- ding van een geneesmiddel met neuro-psychotrope werking. | |
NL7701584A (nl) | Werkwijze voor het bereiden van geneesmiddelen met antihypertensieve werking. | |
NL7602776A (nl) | Werkwijze voor het bereiden van een farmaceuti- sche formulering met retardeffect. | |
NL164551C (nl) | Werkwijze voor het bereiden van een geneesmiddel met serum-calcium-verlagende activiteit, onder toepassing daarvan verkregen gevormd geneesmiddel, alsmede werkwijze voor het bereiden van daarvoor geschikte polypeptiden. | |
NL7514976A (nl) | Werkwijze voor het bereiden van d-homo-20- -keto-pregnanen en werkwijze voor het bereiden van een geneesmiddel met anesthetische werking op basis hiervan. | |
NL7706532A (nl) | Werkwijze voor het bereiden van esters met anti- bacteriele werking, alsmede zodanige esters be- vattende farmaceutische preparaten. | |
NL167093C (nl) | Werkwijze voor het bereiden van een farmaceutisch pre- paraat met antimicrobiele werking, alsmede gevormd farmaceutisch preparaat. | |
NL7604016A (nl) | Werkwijze voor het bereiden van prostaglan- dine-derivaten en werkwijze voor de bereiding van een geneesmiddel met prostaglandine-wer- king. | |
NL7505603A (nl) | Werkwijze voor het bereiden van gesubstitueerde fenylguanidinen alsmede de toepassing ervan als geneesmiddel. | |
NL183764C (nl) | Werkwijze voor de bereiding van een geneesmiddel met psychotrope of neurotrope werking en werkwijze voor de bereiding van een histidylprolineamide-derivaat. | |
NL7608651A (nl) | Werkwijze voor het isoleren van chalonen, als- mede werkwijze ter bereiding van een genees- middel met celvorming-regulerende werking. | |
NL7613206A (nl) | Werkwijze voor het bereiden van een geneesmiddel. | |
NL7704585A (nl) | Werkwijze voor het bereiden van een genees- middel. | |
NL190267C (nl) | Werkwijze voor het bereiden van een geneesmiddel met antibacteriele werking en werkwijze voor het bereiden van geneeskrachtige oxadethia-cefalosporinederivaten. | |
NL7711993A (nl) | Werkwijze voor het bereiden van een geneesmiddel van hypoglycemische werking, alsmede het verkregen gevormde geneesmiddel. | |
NL184469C (nl) | Werkwijze voor het bereiden van een geneesmiddel met antitumorwerking op basis van een 1-alkylcarbamoyl-5-uracilderivaat alsmede werkwijze voor het bereiden van hierbij te gebruiken geneeskrachtige 1-alkylcarbamoyl-5-fluoruracilderivaten. | |
NL7612610A (nl) | Werkwijze voor het bereiden van imidazoolver- bindingen en werkwijze voor het bereiden van een geneesmiddel met anti-uricopathetische werking. | |
NL7608810A (nl) | Werkwijze voor het bereiden van pyrazool-deri- vaten en werkwijze voor het bereiden van een geneesmiddel met anti-inflammatorische werking. | |
NL7413385A (nl) | Werkwijze voor het bereiden van een geneesmid- et anti-allergie werking. | |
NL7704218A (nl) | Corticoiden, werkwijze voor het bereiden daar- van, alsmede werkwijze voor het bereiden van een geneesmiddel met anti-inflammatorische werking. | |
NL184898C (nl) | Werkwijze voor het bereiden van aminoandrostaan-derivaten, werkwijze voor het bereiden van een geneesmiddel met neuro-musculair-blokkerende werking en gevormd geneesmiddel met neuro-musculair-blokkerende werking. | |
NL7413376A (nl) | Werkwijze voor het bereiden van een geneesmid- et anti-allergie werking. | |
NL7514554A (nl) | Werkwijze voor het bereiden van een geneesmiddel met ontstekings-remmende werking. | |
NL7412346A (nl) | Werkwijze voor het bereiden van een preparaat met pijnstillende en analgetische werking. | |
NL7713595A (nl) | Corticoiden, werkwijze voor het bereiden daar- van alsmede werkwijze voor het bereiden van een geneesmiddel met anti-flogistische werking. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BA | A request for search or an international-type search has been filed | ||
BB | A search report has been drawn up | ||
BC | A request for examination has been filed | ||
A85 | Still pending on 85-01-01 | ||
BV | The patent application has lapsed |